...
search icon
mltx-img

MoonLake Immunotherapeutics Share Price

MLTX
NAQ
$15.61
-$0.18
(-1.14%)
1D
Industry: Biotechnology Sector: Health Care

MoonLake Immunotherapeutics Analyst Forecast

MoonLake Immunotherapeutics Share Price Chart

MoonLake Immunotherapeutics Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.12B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.01M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.21
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$5.95 L
$62.75 H
$15.61

About MoonLake Immunotherapeutics, Common Stock

MoonLake Immunotherapeutics, a clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland. more

Industry: BiotechnologySector: Health Care

MoonLake Immunotherapeutics Stock Returns

Time FrameMLTXSectorS&P500
1-Week Return5.69%0.91%2.13%
1-Month Return-13.71%-0.72%-0.47%
3-Month Return22.24%2.24%1.29%
6-Month Return-71.54%19.1%7.71%
1-Year Return-64.74%7.15%14.7%
3-Year Return-4.23%16.96%67.75%
5-Year Return36.09%33.23%76.25%
10-Year Return48.81%142.74%271.83%

MoonLake Immunotherapeutics Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue-4.97K12.36K13.16K1.38M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":0.36,"profit":true},{"date":"2022-12-31","value":0.89,"profit":true},{"date":"2023-12-31","value":0.95,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit-(4.97K)(12.36K)(13.16K)(1.38M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-497100,"profit":false},{"date":"2022-12-31","value":-1235800,"profit":false},{"date":"2023-12-31","value":-1315800,"profit":false},{"date":"2024-12-31","value":-138472900,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses105.75K4.57M65.06M54.12M143.09M[{"date":"2020-12-31","value":0.07,"profit":true},{"date":"2021-12-31","value":3.19,"profit":true},{"date":"2022-12-31","value":45.47,"profit":true},{"date":"2023-12-31","value":37.82,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(105.75K)(4.57M)(65.06M)(54.12M)(143.09M)[{"date":"2020-12-31","value":-10575500,"profit":false},{"date":"2021-12-31","value":-457034500,"profit":false},{"date":"2022-12-31","value":-6506141700,"profit":false},{"date":"2023-12-31","value":-5412309600,"profit":false},{"date":"2024-12-31","value":-14309108200,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income(90.84K)(4.54M)(64.47M)(43.98M)(120.96M)[{"date":"2020-12-31","value":-9083800,"profit":false},{"date":"2021-12-31","value":-454265400,"profit":false},{"date":"2022-12-31","value":-6446968500,"profit":false},{"date":"2023-12-31","value":-4398472900,"profit":false},{"date":"2024-12-31","value":-12096220100,"profit":false}]
Income Taxes(206.30K)5.71K36.37K94.39K282.20K[{"date":"2020-12-31","value":-73.1,"profit":false},{"date":"2021-12-31","value":2.02,"profit":true},{"date":"2022-12-31","value":12.89,"profit":true},{"date":"2023-12-31","value":33.45,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations-(4.54M)(50.10M)(52.66M)(121.24M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-454265400,"profit":false},{"date":"2022-12-31","value":-5009810700,"profit":false},{"date":"2023-12-31","value":-5265965700,"profit":false},{"date":"2024-12-31","value":-12124440000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(90.84K)(4.54M)(64.51M)(36.01M)(118.94M)[{"date":"2020-12-31","value":-9083800,"profit":false},{"date":"2021-12-31","value":-454265400,"profit":false},{"date":"2022-12-31","value":-6450605100,"profit":false},{"date":"2023-12-31","value":-3600726000,"profit":false},{"date":"2024-12-31","value":-11893551700,"profit":false}]
EPS (Diluted)(0.01)(0.31)(1.27)(0.76)(1.89)[{"date":"2020-12-31","value":-1,"profit":false},{"date":"2021-12-31","value":-31,"profit":false},{"date":"2022-12-31","value":-127,"profit":false},{"date":"2023-12-31","value":-76,"profit":false},{"date":"2024-12-31","value":-189,"profit":false}]

MoonLake Immunotherapeutics Ratios

MoonLake Immunotherapeutics Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

MLTX
Cash Ratio 7.87
Current Ratio 8.50

MoonLake Immunotherapeutics Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MLTX
ROA (LTM) -30.72%
ROE (LTM) -54.33%

MoonLake Immunotherapeutics Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MLTX
Debt Ratio Lower is generally better. Negative is bad. 0.30
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.70

MoonLake Immunotherapeutics Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MLTX
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 3.87
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is MoonLake Immunotherapeutics share price today?

MoonLake Immunotherapeutics (MLTX) share price today is $15.61

Can Indians buy MoonLake Immunotherapeutics shares?

Yes, Indians can buy shares of MoonLake Immunotherapeutics (MLTX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MLTX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of MoonLake Immunotherapeutics be purchased?

Yes, you can purchase fractional shares of MoonLake Immunotherapeutics (MLTX) via the Vested app. You can start investing in MoonLake Immunotherapeutics (MLTX) with a minimum investment of $1.

How to invest in MoonLake Immunotherapeutics shares from India?

You can invest in shares of MoonLake Immunotherapeutics (MLTX) via Vested in three simple steps:

  • Click on Sign Up or Invest in MLTX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in MoonLake Immunotherapeutics shares
What is MoonLake Immunotherapeutics 52-week high and low stock price?

The 52-week high price of MoonLake Immunotherapeutics (MLTX) is $62.75. The 52-week low price of MoonLake Immunotherapeutics (MLTX) is $5.95.

What is MoonLake Immunotherapeutics price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of MoonLake Immunotherapeutics (MLTX) is

What is MoonLake Immunotherapeutics price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of MoonLake Immunotherapeutics (MLTX) is 3.87

What is MoonLake Immunotherapeutics dividend yield?

The dividend yield of MoonLake Immunotherapeutics (MLTX) is 0.00%

What is the Market Cap of MoonLake Immunotherapeutics?

The market capitalization of MoonLake Immunotherapeutics (MLTX) is $1.12B

What is MoonLake Immunotherapeutics's stock symbol?

The stock symbol (or ticker) of MoonLake Immunotherapeutics is MLTX

How Can Investors Use MoonLake Immunotherapeutics Share Price Data for Long-Term Investment Decisions?

Consider the share price of MoonLake Immunotherapeutics as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether MoonLake Immunotherapeutics has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from MoonLake Immunotherapeutics shares for Indian investors?

When investing in MoonLake Immunotherapeutics shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the MoonLake Immunotherapeutics stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare MoonLake Immunotherapeutics share price with other stocks in the same sector?

Rather than merely checking the share price of MoonLake Immunotherapeutics and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that MoonLake Immunotherapeutics stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top